Cyclo Therapeutics Inc. (CYTH)
NASDAQ: CYTH
· Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
Cyclo Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 928.01K | 1.12M | 3M | 9.25M | 1.8M | 841.53K | 915.18K | 1.54M | 4.29M | 7.45M | 11.8M | 16.61M | 8.44M | 11.46M | 15.51M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.28K | 18.52K | 28.36K | 38.94K |
Other Long-Term Assets | 1.97M | n/a | n/a | n/a | n/a | -94.7K | -103.76K | -56.66K | -65.73K | -64.78K | n/a | n/a | n/a | n/a | n/a |
Receivables | 187.68K | 83.74K | 71.32K | 122.38K | 303.76K | 88.39K | 131.22K | 54.99K | 394.57K | 438.69K | 157.72K | 539.09K | 399.93K | 224.48K | 220.17K |
Inventory | 236.11K | 241.03K | 242.53K | 254.35K | 209.75K | 236.64K | 244.5K | 254.49K | 271.14K | 260.61K | 221.06K | 227.44K | 253.8K | 268.93K | 257.83K |
Other Current Assets | n/a | n/a | n/a | n/a | 3.2M | 3.38M | 2.7M | 2.31M | 3.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 3.26M | 4.45M | 6.57M | 12.32M | 5.51M | 4.55M | 3.99M | 4.16M | 8.42M | 11.78M | 15.85M | 19.44M | 10.99M | 14.12M | 18.02M |
Property-Plant & Equipment | 26.64K | 267.72K | 593.82K | 929.28K | 85.55K | 94.7K | 103.76K | 56.66K | 65.73K | 64.78K | 73.93K | 77.22K | 85.83K | 94.45K | 81.22K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2M | 267.72K | 593.82K | 929.28K | 85.55K | 94.7K | 103.76K | 56.66K | 65.73K | 64.78K | 73.93K | 84.5K | 104.35K | 122.81K | 120.16K |
Total Assets | 5.25M | 4.72M | 7.16M | 13.25M | 5.6M | 4.64M | 4.1M | 4.22M | 8.49M | 11.84M | 15.92M | 19.52M | 11.1M | 14.24M | 18.14M |
Account Payables | 5.02M | 3.86M | 3.67M | 4.86M | 6.6M | 6.08M | 4.48M | 2.23M | 2.87M | 2.09M | 2.86M | 3.68M | 3.29M | 2.93M | 3.63M |
Deferred Revenue | 369.14K | n/a | n/a | n/a | -6.6M | -6.08M | -4.48M | n/a | -2.87M | -2.09M | -2.86M | -3.68M | -3.29M | -3.02M | -3.63M |
Short-Term Debt | 12.18M | 2.71M | n/a | 1.01M | 17.97K | 17.47K | 16.97K | n/a | 4.98K | 9.8K | 14.56K | 133.71K | 106.84K | 86.88K | 60.14K |
Other Current Liabilities | 615.89K | 1.78M | 1.22M | 580.14K | -17.97K | -17.47K | -16.97K | 902.61K | -4.98K | -9.8K | -14.56K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 18.72M | 9.83M | 6.54M | 8.47M | 6.62M | 6.1M | 4.5M | 3.48M | 2.88M | 2.1M | 2.88M | 3.83M | 3.42M | 3.04M | 3.71M |
Long-Term Debt | n/a | n/a | n/a | 22.48K | 27.26K | 31.94K | 36.53K | n/a | n/a | n/a | n/a | 18.03K | 44.91K | 71.64K | 98.38K |
Other Long-Term Liabilities | n/a | n/a | n/a | -22.48K | -27.26K | -31.94K | -36.53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 7.14K | 12.38K | 17.51K | 22.48K | 27.26K | 31.94K | 36.53K | 3.48M | 2.88M | 2.1M | 2.88M | 18.03K | 49.89K | 82.03K | 112.94K |
Total Liabilities | 18.73M | 9.84M | 6.55M | 8.49M | 6.65M | 6.13M | 4.54M | 3.48M | 2.88M | 2.1M | 2.88M | 3.85M | 3.47M | 3.12M | 3.82M |
Total Debt | 12.21M | 3M | 665.06K | 1.03M | 45.23K | 49.41K | 53.5K | n/a | 4.98K | 9.8K | 14.56K | 170.99K | 175.61K | 186.93K | 191.41K |
Common Stock | 2.88K | 2.87K | 2.86K | 2.86K | 1.94K | 1.53K | 1.06K | 849.00 | 846.00 | 844.00 | 842.00 | 841.00 | 646.00 | 644.00 | 635.00 |
Retained Earnings | -103.01M | -94.18M | -88.2M | -83.86M | -78.21M | -73.44M | -68.81M | -63.8M | -58.82M | -54.57M | -51.12M | -48.35M | -45.56M | -41.7M | -38.1M |
Comprehensive Income | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | n/a | 0.00 | -0.00 |
Shareholders Equity | -13.47M | -5.12M | 610.01K | 4.76M | -1.05M | -1.48M | -438.88K | 734.54K | 5.61M | 9.74M | 13.05M | 15.67M | 7.63M | 11.13M | 14.32M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.28K | 18.52K | 28.36K | 38.94K |